TL;DR
Overall, CALLY serves as an independent predictor of RA disease activity and provides a clinically meaningful assessment of patients nutritional status and immune reserves.
Background/Aims: This study aimed to assess the utility of the neutrophil‑to‑lymphocyte ratio (NLR), C‑reactive protein (CRP), and skin lesion severity for identifying arthritic manifestations in individuals with psoriasis. Materials and Methods: A total of 102 patients with psoriasis vulgaris (PsV), 74 with psoriatic...
Background The C‐reactive protein–albumin–lymphocyte (CALLY) index, a novel composite marker derived from lymphocyte count, serum albumin, and C‐reactive protein (CRP) levels, is commonly used to assess nutritional and inflammatory status. However, existing studies have not clarified the association between the CALLY i...
INTRODUCTION This study aimed to evaluate the association between the Aggregate Index of Systemic Inflammation (AISI) and the C-reactive protein/albumin ratio (CAR) and the severity of sepsis and 28-d survival outcomes. METHODS This retrospective cohort study enrolled 283 patients with sepsis, who were classified int...
BACKGROUND To investigate the correlation between the C-reactive protein-Albumin-Lymphocyte (CALLY) index, Systemic Immune-inflammation Index (SII), and Aggregate Systemic Inflammation Index (AISI), which are comprehensive biomarkers of inflammatory status, and female stress urinary incontinence (SUI). METHODS Based...
Background: Celiac disease is an enteropathy characterized by intestinal inflammation and systemic immune activation. In recent years, there has been a rising focus on systemic inflammation markers obtained from complete blood count parameters, including the Systemic Immune-Inflammation Index (SII) and the Systemic Inf...
ESR and CAR significantly differentiate psoriasis patients from controls and can complement clinical assessment in psoriasis management, and these cost-effective biomarkers can complement clinical assessment in psoriasis management.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
